Quality of Life of Patients With Locally Advanced and Metastatic Prostate Cancer

NCT ID: NCT02853409

Last Updated: 2018-12-21

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

628 participants

Study Classification

OBSERVATIONAL

Study Start Date

2014-01-31

Study Completion Date

2015-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to evaluate possible changes in quality of life related to health (HRQL) in locally advanced and metastatic prostate cancer patients, after one year of follow-up.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Prostate Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Men ≥ 18 years old
* Symptomatic prostate cancer patients who present symptoms due to prostate cancer disease
* Capacity to comply with the protocol
* Patient with an expected survival \> 12 months

Exclusion Criteria

* Patients who are also participating in any other clinical study
* Patient with other malignant diseases, apart from prostate cancer
Minimum Eligible Age

18 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Ipsen

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Ipsen Medical Director

Role: STUDY_DIRECTOR

Ipsen

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hospital Quirón Campo de Gibraltar

Cadiz, , Spain

Site Status

H. San Juan de Dios

Córdoba, , Spain

Site Status

Hospital Quiron Vizcaya

Erandio, , Spain

Site Status

H. Can Misses

Ibiza Town, , Spain

Site Status

Hospital San Juan de Dios

León, , Spain

Site Status

H. de Torrelodones

Madrid, , Spain

Site Status

H. Montepríncipe

Madrid, , Spain

Site Status

Hospital Quirón San Camilo

Madrid, , Spain

Site Status

Hospital San Rafael

Madrid, , Spain

Site Status

Hospital Quirón Marbella

Marbella, , Spain

Site Status

Hospital Parque San Antonio

Málaga, , Spain

Site Status

H. Infanta Sofía

San Sebastián de los Reyes, , Spain

Site Status

Hospital NISA

Seville, , Spain

Site Status

Hospital Sagrado Corazón

Seville, , Spain

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Spain

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

A-92-52014-215

Identifier Type: -

Identifier Source: org_study_id